Latest News and Press Releases

BEIJING, June 15, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

BEIJING, June 4, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

1Q12 Revenue was RMB60.3 Million ($9.6 Million) 1Q12 Net Income was RMB0.7 Million ($0.1 Million) 1Q12 Non-GAAP Adjusted Net Income was RMB1.4 Million ($0.2 Million) Live conference call to be...

BEIJING, May 21, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

BEIJING, May 10, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

BEIJING, May 9, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

BEIJING, March 14, 2012 (GLOBE NEWSWIRE) -- Following a release published earlier today by China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP), please note that subheading for the non-GAAP...

4Q11 Revenue was RMB57.0 Million ($9.1 Million) 4Q11 Non-GAAP Adjusted Net Loss was RMB6.3 Million ($1.0 million) FY11 Revenue was RMB288.3 Million ($45.8 Million) FY11 Non-GAAP Adjusted Net...

BEIJING, Feb. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a fully integrated, China-based biopharmaceutical company focused on the...

BEIJING, Feb. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a fully integrated, China-based biopharmaceutical company focused on the...